Enfurvitide prevents vertical transmission of multidrug-resistant HIV-1 in pregnancy but does not cross the placenta

Abstract excerpt

The use of previously successful antiretroviral regimens in mother-to-child transmission (MTCT) prevention will be increasingly challenged by the rising prevalence of multidrug-resistant (MDR) HIV. We used enfurvitide together with an optimized antiretroviral backbone to prevent the MTCT prevention of MDR HIV in two pregnant women. The measurement of maternal and foetal peripheral blood levels of enfurvitide...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to HIV/AIDS Research and Interventions
• Share to HIV-related health complications and treatments
• Share to HIV Research and Treatment